These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 32640516)
1. Human Endogenous Retrovirus K in Cancer: A Potential Biomarker and Immunotherapeutic Target. Curty G; Marston JL; de Mulder Rougvie M; Leal FE; Nixon DF; Soares MA Viruses; 2020 Jul; 12(7):. PubMed ID: 32640516 [TBL] [Abstract][Full Text] [Related]
2. Upregulation of human endogenous retrovirus-K (HML-2) mRNAs in hepatoblastoma: Identification of potential new immunotherapeutic targets and biomarkers. Grabski DF; Ratan A; Gray LR; Bekiranov S; Rekosh D; Hammarskjold ML; Rasmussen SK J Pediatr Surg; 2021 Feb; 56(2):286-292. PubMed ID: 32682541 [TBL] [Abstract][Full Text] [Related]
3. Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer. Wang-Johanning F; Li M; Esteva FJ; Hess KR; Yin B; Rycaj K; Plummer JB; Garza JG; Ambs S; Johanning GL Int J Cancer; 2014 Feb; 134(3):587-95. PubMed ID: 23873154 [TBL] [Abstract][Full Text] [Related]
4. HIV-1 Infection of Primary CD4 Young GR; Terry SN; Manganaro L; Cuesta-Dominguez A; Deikus G; Bernal-Rubio D; Campisi L; Fernandez-Sesma A; Sebra R; Simon V; Mulder LCF J Virol; 2018 Jan; 92(1):. PubMed ID: 29046457 [TBL] [Abstract][Full Text] [Related]
5. Disruption by SaCas9 Endonuclease of HERV-K Ibba G; Piu C; Uleri E; Serra C; Dolei A Viruses; 2018 Aug; 10(8):. PubMed ID: 30087231 [TBL] [Abstract][Full Text] [Related]
6. Human endogenous retroviruses and cancer prevention: evidence and prospects. Cegolon L; Salata C; Weiderpass E; Vineis P; Palù G; Mastrangelo G BMC Cancer; 2013 Jan; 13():4. PubMed ID: 23282240 [TBL] [Abstract][Full Text] [Related]
7. Exploring HERV-K (HML-2) Influence in Cancer and Prospects for Therapeutic Interventions. Costa B; Vale N Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834078 [TBL] [Abstract][Full Text] [Related]
8. Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals. Contreras-Galindo R; Kaplan MH; Contreras-Galindo AC; Gonzalez-Hernandez MJ; Ferlenghi I; Giusti F; Lorenzo E; Gitlin SD; Dosik MH; Yamamura Y; Markovitz DM J Virol; 2012 Jan; 86(1):262-76. PubMed ID: 22031938 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of Human Endogenous Retrovirus Type K (HERV-K) Viral Li M; Radvanyi L; Yin B; Rycaj K; Li J; Chivukula R; Lin K; Lu Y; Shen J; Chang DZ; Li D; Johanning GL; Wang-Johanning F Clin Cancer Res; 2017 Oct; 23(19):5892-5911. PubMed ID: 28679769 [No Abstract] [Full Text] [Related]
10. Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors. Wang-Johanning F; Rycaj K; Plummer JB; Li M; Yin B; Frerich K; Garza JG; Shen J; Lin K; Yan P; Glynn SA; Dorsey TH; Hunt KK; Ambs S; Johanning GL J Natl Cancer Inst; 2012 Feb; 104(3):189-210. PubMed ID: 22247020 [TBL] [Abstract][Full Text] [Related]
11. The Role of HERV-K in Cancer Stemness. Rivas SR; Valdez MJM; Govindarajan V; Seetharam D; Doucet-O'Hare TT; Heiss JD; Shah AH Viruses; 2022 Sep; 14(9):. PubMed ID: 36146825 [TBL] [Abstract][Full Text] [Related]
12. Human endogenous retroviruses and cancer: causality and therapeutic possibilities. Mullins CS; Linnebacher M World J Gastroenterol; 2012 Nov; 18(42):6027-35. PubMed ID: 23155332 [TBL] [Abstract][Full Text] [Related]
13. The role of endogenous retroviruses-K in human cancer. Salavatiha Z; Soleimani-Jelodar R; Jalilvand S Rev Med Virol; 2020 Nov; 30(6):1-13. PubMed ID: 32734655 [TBL] [Abstract][Full Text] [Related]
14. Digital expression profiles of human endogenous retroviral families in normal and cancerous tissues. Stauffer Y; Theiler G; Sperisen P; Lebedev Y; Jongeneel CV Cancer Immun; 2004 Feb; 4():2. PubMed ID: 14871062 [TBL] [Abstract][Full Text] [Related]
15. HIV-1 infection leads to increased transcription of human endogenous retrovirus HERV-K (HML-2) proviruses in vivo but not to increased virion production. Bhardwaj N; Maldarelli F; Mellors J; Coffin JM J Virol; 2014 Oct; 88(19):11108-20. PubMed ID: 25056891 [TBL] [Abstract][Full Text] [Related]
16. HERV-K(HML-2), a seemingly silent subtenant - but still waters run deep. Hanke K; Hohn O; Bannert N APMIS; 2016; 124(1-2):67-87. PubMed ID: 26818263 [TBL] [Abstract][Full Text] [Related]
17. Human endogenous retrovirus HERV-K(HML-2) Rec expression and transcriptional activities in normal and rheumatoid arthritis synovia. Ehlhardt S; Seifert M; Schneider J; Ojak A; Zang KD; Mehraein Y J Rheumatol; 2006 Jan; 33(1):16-23. PubMed ID: 16395745 [TBL] [Abstract][Full Text] [Related]
18. Contribution of Human Retroviruses to Disease Development-A Focus on the HIV- and HERV-Cancer Relationships and Treatment Strategies. Liu CH; Grandi N; Palanivelu L; Tramontano E; Lin LT Viruses; 2020 Aug; 12(8):. PubMed ID: 32759845 [TBL] [Abstract][Full Text] [Related]
19. Human Endogenous Retroviruses-K (HML-2) Expression Is Correlated with Prognosis and Progress of Hepatocellular Carcinoma. Ma W; Hong Z; Liu H; Chen X; Ding L; Liu Z; Zhou F; Yuan Y Biomed Res Int; 2016; 2016():8201642. PubMed ID: 28070518 [No Abstract] [Full Text] [Related]
20. Development of an antigen-capture ELISA for the detection of the p27-CA protein of HERV-K(HML-2). Hohn O; Mostafa S; Norley S; Bannert N J Virol Methods; 2016 Aug; 234():186-92. PubMed ID: 27142113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]